PT  - JOURNAL ARTICLE
AU  - Luckie, M
AU  - Khattar, R S
AU  - Fraser, D
TI  - Non-cardiac surgery and antiplatelet therapy following coronary artery stenting
AID  - 10.1136/hrt.2008.161273
DP  - 2009 Aug 15
TA  - Heart
PG  - 1303--1308
VI  - 95
IP  - 16
4099  - http://heart.bmj.com/content/95/16/1303.short
4100  - http://heart.bmj.com/content/95/16/1303.full
SO  - Heart2009 Aug 15; 95
AB  - Coronary artery stenting is increasingly used as a treatment for coronary artery disease. A period of antiplatelet therapy is mandatory following coronary stenting, in order to minimise the risk of stent thrombosis. About 5% of patients who undergo coronary stenting will require non-cardiac surgery within 12 months, and the management of antiplatelet therapy in this setting is complex, requiring a balance between the risks of both operative haemorrhage and stent thrombosis. The available evidence to guide decision-making in the management of antiplatelet therapy in this setting is reviewed.